CREATION.co

Meet the Author

Nathan Cripps

Articles by Nathan Cripps

BCG is seen as a possible ‘game changer’ in COVID-19 treatment

16.04.2020 | Article

BCG is seen as a possible ‘game changer’ in COVID-19 treatment

BCG is seen as a possible ‘game changer’ in COVID-19 treatment

By Nathan Cripps

FDA Tracker: HCPs share migraine and heart treatment approvals

11.03.2020 | Article

FDA Tracker: HCPs share migraine and heart treatment approvals

FDA Tracker: HCPs share migraine and heart treatment approvals

By Nathan Cripps

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

11.02.2020 | Article

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

By Nathan Cripps

FDA Tracker: HCPs excited for Keytruda® approval but share reservations about Vascepa®

14.01.2020 | Article

FDA Tracker: HCPs excited for Keytruda® approval but share reservations about Vascepa®

FDA Tracker: HCPs excited for Keytruda® approval but share reservations about Vascepa®

By Nathan Cripps

FDA Tracker: Oxbryt and Tecentriq discussed the most by healthcare professionals in November

13.12.2019 | Article

FDA Tracker: Oxbryt and Tecentriq discussed the most by healthcare professionals in…

FDA Tracker: Oxbryt and Tecentriq discussed the most by healthcare professionals in November

By Nathan Cripps

A new hope’ found in the FDA approvals of Entresto and Farxiga

14.11.2019 | Article

‘A new hope’ found in the FDA approvals of Entresto and Farxiga

‘A new hope’ found in the FDA approvals of Entresto and Farxiga

By Nathan Cripps

Game changing' month as Erleada® and Rybelsus® approved by the FDA

17.10.2019 | Article

Game changing’ month as Erleada® and Rybelsus® approved by the FDA

Game changing' month as Erleada® and Rybelsus® approved by the FDA

By Nathan Cripps

HCPs encourage peers to carry naloxone to save lives

07.10.2019 | Article

HCPs encourage peers to carry naloxone to save lives

It has been noted that the opioid crisis, which is the result of the misuse of opioids

By Nathan Cripps

Rinvoq and Pretomanid spark HCP interest after gaining FDA approval

13.09.2019 | Article

Rinvoq and Pretomanid spark HCP interest after gaining FDA approval

Rinvoq and Pretomanid spark HCP interest after gaining FDA approval

By Nathan Cripps

What US healthcare professionals were thinking about pancreatic cancer during #ASCO19

19.06.2019 | Article

What US healthcare professionals were thinking about pancreatic cancer during #ASCO19

What US healthcare professionals were thinking about pancreatic cancer during #ASCO19

By Nathan Cripps

Healthcare professionals excited by emerging treatments for prostate cancer

15.04.2019 | Article

Healthcare professionals excited by emerging treatments for prostate cancer

Healthcare professionals excited by emerging treatments for prostate cancer

By Nathan Cripps